September 3, 2013 – St. Jude Medical Inc. announced U.S. Food and Drug Administration (FDA) approval and first use of ...
August 20, 2013 — St. Jude Medical Inc. announced the acquisition of Endosense SA, a Switzerland-based company that has ...
(Editor's note - this article had links to newer content added April 2017) There have been several advances in ...
One of the exciting new frontiers for interventional cardiology is the use of renal denervation therapy to treat ...
July 24, 2013 — St. Jude Medical Inc. announced regulatory approval from the Japanese Ministry of Health, Labor and ...
June 28, 2013 — St. Jude Medical Inc. announced CE mark approval of its next-generation quadripolar device, the Quadra ...
June 6, 2013 — Data presented at Heart Rhythm 2013 shows that Medtronic Inc. Lead Integrity Alert (LIA) software ...
June 3, 2013 — St. Jude Medical Inc. announced that the company’s EnligHTN multi-electrode renal denervation system ...
May 16, 2013 — St. Jude Medical gained CE mark approval of its Ilumien Optis percutaneous coronary intervention (PCI) ...
May 16, 2013 — St. Jude Medical Inc. has received CE Mark approval of its Ellipse and SJM Assura portfolio of ...